started · updated
Taiwan medical experts call for expanded insurance coverage for lung cancer immunotherapy
Medical professionals and the Cancer Hope Foundation in Taiwan are urging the government to review and expand National Health Insurance coverage for advanced lung cancer treatments. The call follows reports of patients facing extreme financial burdens, with some families considering selling property to afford immunotherapy costs that can reach millions of TWD annually.
Experts highlighted the challenges faced by patients with small cell lung cancer and squamous cell lung cancer. These types are often diagnosed at late stages due to subtle early symptoms. For small cell lung cancer, the five-year survival rate for stage four patients is approximately 3.2 percent, while for squamous cell lung cancer, it is 6.4 percent.
While new immunotherapies and bispecific T-cell engagers (BiTE) offer potential to extend survival, many remain out-of-pocket expenses. Doctors emphasized that early detection through screening and addressing the high cost of genetic testing and specialized drugs are critical to improving patient outcomes and reducing the economic strain on families.
Entities
Cancer Hope Foundation · Taichung Veterans General Hospital · Taiwan · Tu Cheng Hospital